| 000 | 01870 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250518055040.0 | ||
| 264 | 0 | _c20200427 | |
| 008 | 202004s 0 0 eng d | ||
| 022 | _a2405-8521 | ||
| 024 | 7 |
_a10.1016/j.pvr.2019.100181 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAlkhilaiwi, Faris | |
| 245 | 0 | 0 |
_aHigh-throughput screening identifies candidate drugs for the treatment of recurrent respiratory papillomatosis. _h[electronic resource] |
| 260 |
_bPapillomavirus research (Amsterdam, Netherlands) _c12 2019 |
||
| 300 |
_a100181 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aBiopsy |
| 650 | 0 | 4 | _aCell Culture Techniques |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDisease Susceptibility |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 |
_aDrug Discovery _xmethods |
| 650 | 0 | 4 |
_aHigh-Throughput Screening Assays _xmethods |
| 650 | 0 | 4 |
_aHuman papillomavirus 6 _xphysiology |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMicrobial Sensitivity Tests |
| 650 | 0 | 4 |
_aPapillomavirus Infections _xcomplications |
| 650 | 0 | 4 |
_aRespiratory Tract Infections _xdrug therapy |
| 700 | 1 | _aPaul, Siddartha | |
| 700 | 1 | _aZhou, Dan | |
| 700 | 1 | _aZhang, Xiaohu | |
| 700 | 1 | _aWang, Feibai | |
| 700 | 1 | _aPalechor-Ceron, Nancy | |
| 700 | 1 | _aWilson, Kelli | |
| 700 | 1 | _aGuha, Rajarshi | |
| 700 | 1 | _aFerrer, Marc | |
| 700 | 1 | _aGrant, Nazaneen | |
| 700 | 1 | _aThomas, Craig | |
| 700 | 1 | _aSchlegel, Richard | |
| 700 | 1 | _aYuan, Hang | |
| 773 | 0 |
_tPapillomavirus research (Amsterdam, Netherlands) _gvol. 8 _gp. 100181 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.pvr.2019.100181 _zAvailable from publisher's website |
| 999 |
_c30038257 _d30038257 |
||